ACE and angioedema: Concomitant use of ACE inhibitors and the DPP-IV inhibitor vildagliptin in the Brown et al. meta-analysis showed that patients had an increased risk of angioedema with an odds ratio of 4.57 (95% confidence interval 1.57 to 13.28) [37].